Spaglumic acid

DB08835InvestigationalSmall molecule

Spaglumic acid is the β-aspartyl isoform of N-Acetyl-l-aspartylglutamate, a naturally occurring neurotransmitter, used in allergic eye conditions due to its ability to stabilize mast cells. In eye drops, spaglumic acid is either a magnesium or sodium salt of N-Acetyl-l-aspartylglutamate.

Chemical structure of Spaglumic acid
Mechanism
Curator reviewed
Primary indication
Used in patients with allergic conjunctivitis.Curator reviewed · 3 structured indications
Formula / weight
C11H16N2O8 · 304.255 g/mol (avg)

Resolves to

Clinical / RWD
Structure
InChIKeyGUCKKCMJTSNWCU-BQBZGAKWSA-NSMILESCC(=O)N[C@@H](CC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O
Transporters

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
6Marketed productsAcross 2 countries and 2 labellers
Sign in
2ATC codesIncluding every combination product, plus 6 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Spaglumic acid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account